AI hasn’t taken over clinical trials. It’s taken over the parts of clinical trials nobody wanted to do manually in the first place. Clinicians ...
Since people rely on this type of care for practically everything, be it preventing an illness or managing one, a strong workforce is needed. Now, t...
In 2024 alone, the FDA approved 50 novel therapies, supported by about 31,000 participants in pivotal trials. This is a powerful base of evidence, but it i...
Synergy was demonstrated in a combination arm of GLIX1 and the PARP inhibitor olaparib at low doses, with substantially better efficacy compared t...
Keenova Therapeutics plc announced positive results from its Phase 3 clinical trial of XIAFLEX® (collagenase clostridium histolyticum) for the ...
TEPKINLY® (epcoritamab) plus lenalidomide and rituximab (R2) is the first and only bispecific-based therapy approved in Europe for the treatment of...
Foundational BTKi BRUKINSA plus rituximab reduced the risk of progression or death by 43% versus bendamustine plus rituximab (HR=0.57; p<0.0001), me...
Topline results from Phase 3 EPCORE® DLBCL-4 trial evaluating epcoritamab in combination with lenalidomide demonstrated statist...
Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announ...
The study achieved the primary endpoint of non-inferiority, with a rate of all-cause mortality (ACM) at Day 42 for olorofim of 23.8% and for AmBisome&r...
Rapidly Advancing Five IRD Programs with Four Clinical Data Readouts Expected in 2027 RDH12, MERTK and RHO Programs Expected to Enter Clinical Testing o...
TALVEY® plus daratumumab with or without pomalidomide showed progression-free survival of up to 81.3% and overall survival of up to ...
Results from the Phase 2 EPCORE® DLBCL-3 trial show fixed-duration epcoritamab monotherapy demonstrated early responses in elderly patients with ne...
Acousia Therapeutics GmbH, a clinical-stage biotechnology company pioneering treatments for acute and chronic inner ear hearing loss, announced positive ...
© 2026 Biopharma Boardroom. All Rights Reserved.
